MacLean Michael F 4
4 · Avidity Biosciences, Inc. · Filed Aug 15, 2025
Insider Transaction Report
Form 4
MacLean Michael F
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-08-06$42.73/sh−30,914$1,320,844→ 65,806 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on July 8, 2024.
- [F2]This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $40.15 to $43.92. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.